Article Versions Notes

Tsitsilonis OE, Paraskevis D, Lianidou E, Terpos E, Akalestos A, Pierros V, Kostaki EG, Kastritis E, Moutsatsou P, Politou M, et al. SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response. Vaccines. 2021; 9(3):207. https://doi.org/10.3390/vaccines9030207

Tsitsilonis, Ourania E., Dimitrios Paraskevis, Evi Lianidou, Evangelos Terpos, Athanasios Akalestos, Vassilios Pierros, Evangelia Georgia Kostaki, Efstathios Kastritis, Paraskevi Moutsatsou, Marianna Politou, and et al. 2021. "SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response" Vaccines 9, no. 3: 207. https://doi.org/10.3390/vaccines9030207

Tsitsilonis, O. E., Paraskevis, D., Lianidou, E., Terpos, E., Akalestos, A., Pierros, V., Kostaki, E. G., Kastritis, E., Moutsatsou, P., Politou, M., Scorilas, A., Sphicopoulos, T., Thomaidis, N., Trougakos, I. P., Tsakris, A., Voulgaris, N., Daskalaki, C. C., Evangelakou, Z., Fouki, C., ... Sfikakis, P. P. (2021). SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response. Vaccines, 9(3), 207. https://doi.org/10.3390/vaccines9030207